Articles by Sean Milmo - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Sean Milmo

Sean Milmo


Sean Milmo is a freelance writer based in Essex, United Kingdom.

Articles
Tackling Drug Shortages
November 2, 2014

Resolving the problem will require more communication between the industry and regulatory bodies.

WHO Promotes International Collaboration for Generic Drug Approvals
November 1, 2014

The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.

Harmonizing Marketing Approval of Generic Drugs in Europe
October 2, 2014

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

Extending the Scope of Pharmacovigilance Comes at a Price
September 2, 2014

As the pharmacovigilance infrastructure becomes more entrenched in Europe, drug manufacturers are beginning to feel the burden of its high cost.

Collaboration and Innovation in European Medicine Regulation
August 1, 2014

The European Union has developed a system for evaluating, approving and monitoring the safety of medicines that has also encouraged innovation.

Regulating the Environmental Impact of Pharmaceuticals
June 2, 2014

Concern by environmentalists, regulators and manufacturers rises over the environmental impact of pharmaceuticals.

EU Steps Up Inspection Efforts
May 2, 2014

The rising incidence of medicine defects and shortages stemming from sub-standard manufacturing is forcing Europe to give higher prominence to more effective inspections procedures.

Quality by Design—Bridging the Gap between Concept and Implementation
April 2, 2014

As Europe strives to firmly incorporate quality-by-design principles, there are several key issues that still need to be addressed.

European Union Packaging Safety Features Come into Effect
March 2, 2014

Manufacturers are taking measures to comply with new package safety rules.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here